# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a fav...
Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic ...
To gain an edge, this is what you need to know today.
The Biden admin revoked export licenses to Intel and Qualcomm, escalating US efforts to curb Huawei's tech ascent due to na...
https://www.ft.com/content/cf965960-b083-49ee-bae1-6ce95fe872a3